Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
04 Outubro 2024 - 5:30PM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the
Guggenheim Global Healthcare Conference on Tuesday, November 12th,
at the InterContinental Boston in Boston, MA. Biljana Naumovic,
President, Solid Tumor, U.S. Oncology and Mark Wildgust, Vice
President, Global Medical Affairs Oncology, will represent the
Company in a session scheduled at 10:30 a.m. (Eastern Time).
This live audio webcast will be available to investors and other
interested parties by accessing the Johnson & Johnson website
at www.investor.jnj.com.
The audio webcast replay will be available approximately 48
hours after the webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241004735017/en/
Media contact: media-relations@its.jnj.com
Investor contact: investor-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
